During the past decade, Illinois CancerCare - Washington conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 77 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare - Washington" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "SWOG Cancer Research Network" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare - Washington" #1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Brain Science Foundation" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare - Washington" are "Stage IIIB Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Clinical Stage III Cutaneous Melanoma AJCC v8" (4 trials) and "Clinical Stage IV Cutaneous Melanoma AJCC v8" (4 trials). Many other conditions were trialed in "Illinois CancerCare - Washington" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare - Washington" are "Drug" (81 trials), "Other" (57 trials), "Biological" (53 trials), "Procedure" (50 trials) and "Radiation" (21 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (36 trials), "Quality-of-Life Assessment" (36 trials), "Biospecimen Collection" (32 trials), "Questionnaire Administration" (29 trials) and "Magnetic Resonance Imaging" (27 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare - Washington" are 95 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare - Washington". undefined are not yet recruiting, 75 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Illinois CancerCare - Washington, 7 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare - Washington, 1 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".